DAX22.272 +0,1%ESt505.170 +0,3%Top 10 Crypto12,13 -3,7%Dow40.228 +0,3%Nas17.366 -0,1%Bitcoin83.639 +0,4%Euro1,1394 -0,2%Öl65,67 ±0,0%Gold3.325 -0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Tesla A1CX3T RENK RENK73 BYD A0M4W9 Lufthansa 823212 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Telekom 555750 Siemens Energy ENER6Y Allianz 840400 Volkswagen (VW) vz. 766403 Amazon 906866 Bayer BAY001 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt im Plus -- US-Börsen schließen uneinheitlich -- Akzo Nobel hat wohl Interesse an BASF-Lacke-Geschäft -- Merck: SpringWorks-Übernahme gesichert -- D-Wave Quantum, NVIDIA, Ripple im Fokus
Top News
NVIDIA-Aktie im Visier: Chinas Tech-Giganten sichern sich NVIDIA-Chips vor Exportstopp NVIDIA-Aktie im Visier: Chinas Tech-Giganten sichern sich NVIDIA-Chips vor Exportstopp
Apple-Aktie im Blick: Darum sollten sich Anleger auf eine Schwächephase einstellen Apple-Aktie im Blick: Darum sollten sich Anleger auf eine Schwächephase einstellen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Europäische Aktien bieten Grund für Optimismus. Ihre Aussichten könnten langfristig besser sein als für die erfolgsverwöhnten US-Titel. DWS informiert

Prominent Life Sciences Partner Rejoins Latham's Bay Area Offices

28.04.25 20:38 Uhr

Dr. Kate Hillier brings extensive experience in strategic IP counseling and licensing as well as collaboration transactions for life sciences companies.

SAN FRANCISCO, April 28, 2025 /PRNewswire/ -- Latham & Watkins LLP1 is pleased to announce that Dr. Kate Hillier has rejoined the firm's Bay Area offices as a partner in the Healthcare & Life Sciences Practice. Hillier represents public and private life sciences companies on complex licensing and collaboration transactions, with a particular focus on counseling clients on strategic partnering and related intellectual property (IP), business and legal issues.

Kate Hillier, Partner, Latham & Watkins

"We are thrilled to welcome Kate back to Latham," said Mark Bekheit, Office Managing Partner of Latham's Bay Area offices. "Her expertise in advising on licensing and collaboration transactions and partnering strategy will lend important support to our growing Emerging Companies & Growth Practice, while enhancing our general corporate, M&A, and regulatory offerings where they intersect with the life sciences and healthcare industry."

Hillier draws on her academic and clinical experience to maximize the value of clients' products and technologies, regularly advising companies on strategic intellectual property licensing, collaboration agreements, and structuring and negotiating critical transactions. She also counsels clients on matters involving foundational in-licenses and complex commercial arrangements.

John Manthei, Global Chair of Latham's Healthcare & Life Sciences Practice, said, "Kate's expertise in strategic partnering and her ability to navigate complex transactions align with our practice's goals and increasing client demands. Her return underscores Latham's role as a destination for healthcare and life sciences companies and the top legal talent that service them."

"I am excited to return to Latham and contribute to the firm's fantastic Healthcare & Life Sciences Practice," said Hillier. "Latham's unmatched global platform, depth of expertise in private equity, biotechnology, life sciences and healthcare, and collaborative culture provide the perfect environment for me to continue delivering exceptional service to clients in the life sciences sector."

Hillier rejoins Latham from Cooley. She received her JD from the University of Cambridge (Jesus College), and a Diploma in Legal Practice from the Oxford Institute of Legal Practice. Prior to embarking upon her legal career, she was a qualified anesthesiologist in the UK and Australia.

Notes to Editors

  • Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in Israel through a limited liability company, in South Korea as a Foreign Legal Consultant Office, and in Saudi Arabia through a limited liability company.

    • Contacts

    Mark Bekheit, Office Managing Partner of Latham's Bay Area Offices, +1.650.463.3032

    John Manthei, Global Chair of Latham's Healthcare & Life Sciences Practice, +1.202.637.2211

    (PRNewsfoto/Latham & Watkins)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/prominent-life-sciences-partner-rejoins-lathams-bay-area-offices-302440080.html

    SOURCE Latham & Watkins LLP